Journal article
Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic
LJ Sacks, CT Pham, N Fleming, SL Neoh, EI Ekinci
Diabetes Research and Clinical Practice | ELSEVIER IRELAND LTD | Published : 2020
Abstract
Introduction: The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) continues to cause havoc globally, resulting in unprecedented healthcare, societal and economic disruption. People with diabetes have been shown to be at higher risk of complications and death when exposed to pneumonia, influenza and other coronaviruses. Despite pandemic scale infection, there is currently limited understanding on the potential impact of coronavirus disease (COVID-19) on people with diabetes. Aims: (1) To characterise the outcomes of COVID-19 for people with diabetes and (2) add value to current recommendations for healthcare providers and people with diabetes to encourage optimal management. Met..
View full abstractGrants
Funding Acknowledgements
EIE has received research funding from NHMRC and Sir Edward Weary Dunlop Research Foundation. EIE's institution receives research funding from Novo Nordisk, Bayer, Gilead, Sanofi.